Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant Recipients

Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant Recipients

Background: Molnupiravir demonstrated an in vitro antiviral activity against positive-sense RNA viruses, including SARS-CoV-2. The study aimed to present the results of outpatient molnupiravir use in kidney transplant recipients and hemodialysis patients during the first months of 2022 in Poland. Me...

Full description

Bibliographic Details
Main Authors: Paweł Poznański, Hanna Augustyniak-Bartosik, Anna Magiera-Żak, Karolina Skalec, Katarzyna Jakuszko, Oktawia Mazanowska, Dariusz Janczak, Magdalena Krajewska, Dorota Kamińska
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Viruses
Subjects:
COVID-19
SARS-CoV-2
molnupiravir
ESKD
ESRD
kidney transplantation
Online Access:https://www.mdpi.com/1999-4915/14/10/2224

Internet

https://www.mdpi.com/1999-4915/14/10/2224

Similar Items